Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer

Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidenc...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports Vol. 48; no. 5; pp. 4797 - 4811
Main Authors: Moafian, Zeinab, Maghrouni, Abolfazl, Soltani, Arash, Hashemy, Seyed Isaac
Format: Journal Article
Language:English
Published: Dordrecht Springer Netherlands 01.05.2021
Springer Nature B.V
Subjects:
1-Phosphatidylinositol 3-kinase
AKT protein
Animal Anatomy
Animal Biochemistry
Biomedical and Life Sciences
Cancer
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Histology
Life Sciences
Metastases
metastasis
microRNA
molecular biology
Morphology
mortality
Non-coding RNA
Review
Therapeutic targets
therapeutics
TOR protein
mTOR pathway
AKT
PI3K
Colorectal cancer (CRC)
MicroRNAs
LncRNAs
ISSN:0301-4851, 1573-4978, 1573-4978
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidence has shown the importance of non-coding RNAs such as lncRNAs and miRNAs functions in the development and progression of CRC. However, the exact underlying mechanism of these types of RNAs in CRC is still mostly unknown. PI3K/AKT/mTOR pathway contributes to many cellular processes, and dysregulation of this pathway frequently occurs in cancers. In this review, the authors have mostly focused on the significant non-coding RNAs regulators of the PI3K/AKT/mTOR pathway and their contribution to the development or inhibition of CRC and their potential as diagnostic or therapeutic targets in CRC treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0301-4851
1573-4978
1573-4978
DOI:10.1007/s11033-021-06458-y